ALLIANCE PHARMA PLC

Net Asset Value • Dec 7, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1204I

Alliance Pharma PLC

07 December 2015

	7 December 2015

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Share Options

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that on 4th December 2015 it awarded 2,000,000 share options to Andrew Franklin, the Chief Financial Officer (the "Options"). The Options have an exercise price of 46.75p and vest on 4th December 2018 subject to the achievement of certain performance conditions. The Options represent 0.76% of the current issued ordinary share capital of the Company and will represent 0.43% of the enlarged issued share capital (assuming the maximum number of shares are issued under the Placing and Placing Option announced on 26th November 2015).

For further information:

### Alliance Pharma plc	### + 44 (0) 1249 466966
John Dawson, Chief Executive
Sarah Robinson, Company Secretary
www.alliancepharma.co.uk
### Buchanan	### + 44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Jane Glover
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Freddie Barnfield
Corporate Broking: David Poutney / James Black

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCPKQDQOBDDNBK